We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMFI
3176
DELISTED
Aetherium Acquisition Corp
GMFI
$171K ﹤0.01%
+17,225
New +$171K
BSAC icon
3177
Banco Santander Chile
BSAC
$15.8B
$170K ﹤0.01%
+10,410
New +$202K
ESPR
3178
DELISTED
Esperion Therapeutics
ESPR
$169K ﹤0.01%
+26,600
New +$151K
FXY icon
3179
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$423M
$166K ﹤0.01%
+2,400
New +$173K
RSKD icon
3180
Riskified
RSKD
$672M
$165K ﹤0.01%
37,088
+17,208
+87% +$89.1K
CYXT
3181
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$165K ﹤0.01%
14,607
-94,924
-87% -$1.22M
CORZW
3182
CALL
DELISTED
Core Scientific, Inc. Warrant
CORZW
$164K ﹤0.01%
109,673
-222,463
-67% -$275K
MTAL
3183
DELISTED
Metals Acquisition
MTAL
$161K ﹤0.01%
16,323
ELMS
3184
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$160K ﹤0.01%
1,000,000
MAG
3185
DELISTED
MAG Silver
MAG
$158K ﹤0.01%
+12,970
New +$190K
SLE icon
3186
Super League Enterprise
SLE
$4.28M
$158K ﹤0.01%
16
-29
-64% -$377K
GOEV
3187
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$158K ﹤0.01%
+185
New +$325K
BCAB icon
3188
BioAtla
BCAB
$5.59M
$156K ﹤0.01%
1,091
-692
-39% -$110K
ABST
3189
DELISTED
Absolute Software Corp
ABST
$155K ﹤0.01%
17,878
-19,132
-52% -$160K
CLVS
3190
DELISTED
Clovis Oncology, Inc.
CLVS
$155K ﹤0.01%
+86,243
New +$127K
C icon
3191
PUT
Citigroup
C
$222B
$152K ﹤0.01%
3,300
+100
+3% +$5K
RELY icon
3192
Remitly
RELY
$4.74B
$150K ﹤0.01%
+19,640
New +$195K
LAB icon
3193
Standard BioTools
LAB
$326M
$149K ﹤0.01%
+93,509
New +$231K
QUBT icon
3194
Quantum Computing Inc
QUBT
$1.68B
$149K ﹤0.01%
+62,415
New +$133K
CUK
3195
DELISTED
Carnival PLC
CUK
$147K ﹤0.01%
18,517
-12,537
-40% -$169K
FPI
3196
Farmland Partners
FPI
$419M
$147K ﹤0.01%
10,677
-21,933
-67% -$319K
HYZNW
3197
CALL
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$147K ﹤0.01%
50,000
MNTV
3198
DELISTED
Momentive Global Inc. Common Stock
MNTV
$147K ﹤0.01%
16,897
-86,922
-84% -$1.16M
ACCD
3199
DELISTED
Accolade Inc
ACCD
$146K ﹤0.01%
+19,775
New +$173K
OIG
3200
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$144K ﹤0.01%
5,721
-3,078
-35% -$136K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.